Children's Hospital Colorado
Aurora, Colorado, 80045, United States
NCT Number: NCT05607303
With a rising population of transgender adults and youth, there is a need for more research to meet the needs of this community. Transfemale (MTF) youth (male sex, female gender identity) who begin clinical Gender Affirming Hormone Therapy (GAHT) with estrogen may be at a higher risk for headache since estrogen has been linked to headache in cisgender females (female sex, female gender identity). This research hopes to learn more about headache in MTF youth.
This study is active but is not currently recruiting participants.
9 year–20 year
All sexes
Observational
Aurora, Colorado, 80045, United States
MTF youth who will begin estrogen clinically will be enrolled in the study and will be seen twice, once before starting estrogen and then one year after beginning estrogen. Cisgender males (male sex, male gender identity) will also be enrolled as a control group and will be seen once at the beginning of the study and then once a year later. The researchers will track how often youth have headaches during this time to see if it is different between groups. In a subset of the youth enrolled, an MRI will be completed to also look at brain structure and function.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
For MTF youth (cases):
For cisgender male youth (controls):
Exclusion criteria
No research interventions will be used as a part of the study since the research is observational. Estrogen treatment will be prescribed and followed by participant's clinical physician.
Time frame: 1 year
Measured by headache count from daily headache diary.
Time frame: 1 year
Amygdala volume as measured on MRI.
Time frame: 1 year
Measured by proportion of between-module connectivity patterns vs. within-module connectivity patterns.
University of Colorado, Denver
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06670053
Brain Diseases, Central Nervous System Diseases
Aurora, Colorado, United States
View Trial DetailsNCT07446036
Brain Diseases, Brain Neoplasms
Beijing, Fengtai, China
View Trial DetailsNCT06310200
Brain Freeze, Cold Induced Cephalgia
Dayton, Ohio, United States
View Trial DetailsNCT07725198
Head and Neck, Headache
Fort Myers, Florida, United States
View Trial Details